Secondary Tumors Arising in Patients Undergoing BRAF Inhibitor Therapy Exhibit Increased BRAF-CRAF Heterodimerization.
about
Context-Dependent Effects of Amplified MAPK Signaling during Lung Adenocarcinoma Initiation and Progression.Woman, mother, and scientist: Aiming to fulfill a career in research while maintaining a "good-enough" work-life balance.Unusual Skin Carcinomas Induced by BRAF Inhibitor for Metastatic Melanoma: A Case Report.Dopamine-induced SULT1A3/4 promotes EMT and cancer stemness in hepatocellular carcinoma.Overcoming resistance to BRAF inhibitors.Sequence analysis of RAS and RAF mutation hot spots in canine carcinoma.PIK3CAH1047R-induced paradoxical ERK activation results in resistance to BRAFV600E specific inhibitors in BRAFV600E PIK3CAH1047R double mutant thyroid tumors.Melanocytic lesion evolution patterns with targeted therapies and immunotherapies for advanced metastatic melanoma: An observational study.Co-targeting BET and MEK as salvage therapy for MAPK and checkpoint inhibitor-resistant melanoma.Management of the cutaneous adverse effects of antimelanoma therapySustained activation of the Aryl hydrocarbon Receptor transcription factor promotes resistance to BRAF-inhibitors in melanoma
P2860
Q33604228-2597315A-D35B-4F2C-8B8D-E53D293F6137Q42354696-4C28C056-4190-485D-8590-D455C817F8DEQ42514858-8E966E75-6F5A-4E42-A98F-A6EA2EEDDD38Q42516725-D3239F64-0157-423D-BB16-22FB748AF77EQ43298157-2B8663BA-4027-4B7C-825E-193B61B9F170Q44867413-824BD67E-F2FF-47CF-88DD-F333DD278EAEQ47142625-E083BBBD-6CC6-4EA3-A872-BD0DFEA0DEA6Q48126633-9202B2BE-C0D1-4B89-84F5-D35BE843C7E6Q52591043-D52B43BC-227C-47E2-BF2F-89D53835B1D7Q56893430-14B647D8-D435-467C-B7BB-BAA610B4B03BQ59131878-936142F0-3D4C-403C-A00E-80D7486BD9FC
P2860
Secondary Tumors Arising in Patients Undergoing BRAF Inhibitor Therapy Exhibit Increased BRAF-CRAF Heterodimerization.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Secondary Tumors Arising in Pa ...... BRAF-CRAF Heterodimerization.
@en
type
label
Secondary Tumors Arising in Pa ...... BRAF-CRAF Heterodimerization.
@en
prefLabel
Secondary Tumors Arising in Pa ...... BRAF-CRAF Heterodimerization.
@en
P2093
P1433
P1476
Secondary Tumors Arising in Pa ...... BRAF-CRAF Heterodimerization.
@en
P2093
Alexander M Eggermont
Andrea Cavalcanti
Caroline Robert
Christine Mateus
Emilie Routier
Florent Grange
Gorana Tomasic
Hélène Malka-Mahieu
Isabelle Girault
Julien Adam
P304
P356
10.1158/0008-5472.CAN-15-2900-T
P407
P577
2016-01-29T00:00:00Z